Is diagnostic certainty essential for the use of thrombolytic therapy during myocardial infarction in the 1990s?
Ohman
E M
EM
Department of Medicine, Duke University Medical Center, Durham, NC 27710.
Sigmon
K N
KN
Califf
R M
RM
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy*
D005343:Fibrinolytic Agents